Rhinophototherapy in persistent allergic rhinitis

Previous published results have revealed that Rhinolight® intranasal phototherapy is safe and effective in intermittent allergic rhinitis. The present objective was to assess whether phototherapy is also safe and effective in persistent allergic rhinitis. Thirty-four patients with persistent allergi...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Bella Zsolt
Kiricsi Ágnes
Viharosné Dósa-Rácz Éva
Dallos Attila
Perényi Ádám
Kiss Mária
Koreck Andrea Ildikó
Kemény Lajos
Jóri József
Rovó László
Dokumentumtípus: Cikk
Megjelent: 2017
Sorozat:EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 274 No. 3
doi:10.1007/s00405-016-4358-x

mtmt:3196314
Online Access:http://publicatio.bibl.u-szeged.hu/11103
Leíró adatok
Tartalmi kivonat:Previous published results have revealed that Rhinolight® intranasal phototherapy is safe and effective in intermittent allergic rhinitis. The present objective was to assess whether phototherapy is also safe and effective in persistent allergic rhinitis. Thirty-four patients with persistent allergic rhinitis were randomized into two groups; twenty-five subjects completed the study. The Rhinolight® group was treated with a combination of UV-B, UV-A, and high-intensity visible light, while the placebo group received low-intensity visible white light intranasal phototherapy on a total of 13 occasions in 6 weeks. The assessment was based on the diary of symptoms, nasal inspiratory peak flow, quantitative smell threshold, mucociliary transport function, and ICAM-1 expression of the epithelial cells. All nasal symptom scores and nasal inspiratory peak flow measurements improved significantly in the Rhinolight® group relative to the placebo group and this finding persisted after 4 weeks of follow-up. The smell and mucociliary functions did not change significantly in either group. The number of ICAM-1 positive cells decreased non-significantly in the Rhinolight® group. No severe side-effects were reported during the treatment period. These results suggest that Rhinolight® treatment is safe and effective in persistent allergic rhinitis. © 2016, Springer-Verlag Berlin Heidelberg.
Terjedelem/Fizikai jellemzők:1543-1550
ISSN:0937-4477